Company: TEAM
Filing Date: 2025-01-31
Form Type: 10-Q
Source: 0001650372-25-000009
Chunk: 23

Company: Atlassian Corp
Filing Date: 2025-01-31
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
 expenses and other current assets$36,578 $24,047 Other non-current assets60,673 45,056 Total$97,251 $69,103 The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.

12. Stockholders’ EquityStock-based CompensationA summary of restricted stock unit (“RSU”) activity for the six months ended December 31, 2024 was as follows (in thousands except share and per share data):Number of SharesWeighted Average Grant Date Fair ValueAggregate Intrinsic ValueBalance as of June 30, 202412,696,964 $213.13 $2,245,839 Granted10,445,909 169.02 — Vested(2,995,765)210.29 615,559 Forfeited or cancelled(1,150,693)199.73 — Balance as of December 31, 202418,996,415 $189.33 $4,623,347 As of December 31, 2024, total compensation cost not yet recognized in the condensed consolidated financial statements related to employee and director RSU awards was $2.7 billion.During the six months ended December 31, 2024, the Company did not grant any shares of restricted stock awards (“RSA”). During the six months ended December 31, 2023, the Company granted 301,751 shares of RSA. As of December 31, 2024 and June 30, 2024, there were 104,202 and 156,856 shares of RSA outstanding, respectively. These outstanding shares of RSA are subject to forfeiture or repurchase at the original exercise price during the repurchase period following employee termination, as applicable. The total aggregate intrinsic value of outstanding shares of RSA were $25.4 million and $27.7 million as of December 31, 2024 and June 30, 2024, respectively.Share Repurchase ProgramsIn January 2023, the Board of Directors authorized a program to repurchase up to $1.0 billion of the Company’s outstanding Class A Common Stock (the “2023 Repurchase Program”). In September 2024, the Board of Directors authorized a new program under which the Company may repurchase up to an additional $1.5 billion of the Company